Kiora Pharmaceuticals earnings were $3.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest KPRX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$4.2M, up 23.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, KPRX reported annual earnings of $3.6M, with -127.6% growth. The next KPRX earnings date is May 8, 2025.
Kiora Pharmaceuticals Earnings Reports & History FAQ
What were Kiora Pharmaceuticals's earnings last quarter?
On KPRX's earnings call on Invalid Date, Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q4 2024 earnings per share (EPS) of -$1.15, up 27.78% year over year. Total KPRX earnings for the quarter were -$4.22 million. In the same quarter last year, Kiora Pharmaceuticals's earnings per share (EPS) was -$0.90.
The next KPRX earnings date is Invalid Date. Add KPRX to your watchlist to be reminded of Kiora Pharmaceuticals's next earnings date.
What was KPRX's earnings growth in the past year?
As of Kiora Pharmaceuticals's earnings date in Invalid Date, Kiora Pharmaceuticals's earnings has grown year over year. KPRX earnings in the past year totalled $3.59 million.
Is Kiora Pharmaceuticals profitable or losing money?
As of the last Kiora Pharmaceuticals earnings report, Kiora Pharmaceuticals is currently profitable. Kiora Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $3.59 million, a 128.73% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.